Financial Performance - The company's revenue for Q3 2025 was ¥83,619,771.53, representing a 5.20% increase year-over-year, but a decline of 15.35% for the year-to-date period[5] - The net profit attributable to shareholders for Q3 2025 was ¥2,824,859.40, a decrease of 64.23% compared to the same period last year, and a staggering decline of 291.58% year-to-date[5] - The basic earnings per share for Q3 2025 was ¥0.0404, down 73.17% year-over-year, with a year-to-date figure of -¥0.3215, reflecting a 243.72% decline[5] - The company experienced a 412.46% decline in net profit for Q3 2025, amounting to -¥31,164,865.81, driven by decreased revenue and increased management and sales expenses[9] - Total operating revenue for the current period was ¥162,503,768.56, a decrease of 15.3% compared to ¥191,972,106.49 in the previous period[17] - Net profit for the current period was a loss of ¥31,164,865.81, compared to a profit of ¥9,974,124.80 in the previous period[18] - The total comprehensive income for the period was -31,164,865.81 CNY, compared to 9,974,124.80 CNY in the previous period[19] - Basic and diluted earnings per share were both -0.3215 CNY, a decrease from 0.2237 CNY in the previous period[19] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥1,444,424,998.73, a decrease of 6.50% from the end of the previous year[5] - The company's total assets decreased to ¥1,444,424,998.73 from ¥1,544,892,952.66, reflecting a decline of 6.5%[16] - Total liabilities decreased slightly to ¥537,506,070.78 from ¥557,809,158.90, a reduction of 3.9%[16] - Non-current liabilities increased significantly to ¥151,843,388.01 from ¥89,707,128.11, marking an increase of 69.3%[16] - The total equity attributable to shareholders decreased by 7.54% to ¥876,719,948.78 compared to the end of the previous year[5] - The equity attributable to shareholders decreased to ¥876,719,948.78 from ¥948,221,687.56, a decline of 7.5%[16] Cash Flow - The company's cash flow from operating activities showed a net outflow of ¥50,241,790.06 year-to-date, an increase of 29.04% compared to the previous year[5] - Cash inflow from operating activities totaled 209,596,605.69 CNY, slightly down from 210,655,985.15 CNY year-over-year[20] - Cash outflow from operating activities was 259,838,395.75 CNY, compared to 281,459,539.95 CNY in the previous period[20] - The net cash flow from operating activities was -50,241,790.06 CNY, an improvement from -70,803,554.80 CNY in the previous period[20] - Cash flow from investing activities resulted in a net outflow of -206,768,897.23 CNY, compared to -1,384,652.19 CNY in the previous period[20] - Cash flow from financing activities showed a net outflow of -35,628,374.84 CNY, a decrease from a net inflow of 58,704,066.37 CNY in the previous period[20] - The ending cash and cash equivalents balance was 226,379,281.31 CNY, up from 65,897,437.99 CNY in the previous period[20] Shareholder Information - Total number of common shareholders at the end of the reporting period is 12,895[11] - The largest shareholder, Jiang Jiade, holds 17.70% of shares, totaling 12,391,576 shares[11] - The second-largest shareholder, Zhu Jinsheng, owns 17.50% of shares, amounting to 12,250,000 shares[11] - The company has a total of 10.71% of shares held by Sichuan Jiajin No. 1 Communication Technology Partnership[12] - The company has no preferred shareholders or changes in restricted shares during the reporting period[13] - The company has not reported any significant changes in its financing or share lending activities[12] Expenses - Management expenses increased by 49.77% to ¥41,998,369.60, primarily due to higher salaries and depreciation costs[9] - Total operating costs increased to ¥186,683,687.36, up 4.8% from ¥178,253,738.61 in the previous period[17] - Research and development expenses remained stable at ¥24,923,392.10, compared to ¥24,775,977.24 in the previous period[17] Other Financial Metrics - The company recorded a 64.14% drop in other income, totaling ¥944,070.71, mainly due to a decrease in government subsidies[9] - The company reported a credit impairment loss of ¥-5,853,434.60, compared to a gain of ¥1,086,754.27 in the previous period[18] Audit and Accounting Standards - The company did not undergo an audit for the third quarter financial report[21] - The company plans to implement new accounting standards starting in 2025[21]

Revenue and Profit - Q3 2025 revenue was CNY 334,324,922.43, a decrease of 24.02% year-over-year[4] - Net profit attributable to shareholders was CNY 13,587,766.92, down 35.08% compared to the same period last year[4] - The company reported a 44.29% decline in net profit year-to-date, totaling CNY 39,568,107.96[4] - Basic earnings per share decreased to CNY 0.07, down 36.36% year-over-year[4] - The total profit for the period was 39,568,107.96, a decrease from 71,029,095.53 in the previous period, representing a decline of approximately 44.4%[25] - The net profit margin for the current period was 3.5%, compared to 4.9% in the previous period, indicating a decrease in profitability[25] - The company reported basic earnings per share of 0.21, down from 0.37 in the previous period, representing a decline of 43.2%[25] Cash Flow - Cash flow from operating activities increased significantly to CNY 79,127,858.03, a rise of 921.82% year-to-date[4] - Cash flow from operating activities generated a net amount of 79,127,858.03, significantly up from 7,743,795.26 in the previous period, marking an increase of over 920%[26] - Cash flow from investing activities increased by CNY 297.9641 million, a growth of 76.19%, mainly due to cash management activities[14] - The cash flow from investment activities resulted in a net outflow of -93,108,280.40, an improvement from -391,072,364.73 in the previous period, indicating a reduction in cash outflow[26] - The net cash flow from financing activities was -23,706,566.45, a decrease from 417,651,790.74 in the previous period, indicating a significant reduction in cash inflow[27] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,979,699,873.68, reflecting a 2.65% increase from the end of the previous year[4] - Total current assets decreased to ¥1,473,240,473.42 from ¥1,733,149,139.26, reflecting a reduction of approximately 15.03%[20] - Total non-current assets increased to ¥2,506,459,400.26 from ¥2,143,742,552.34, representing an increase of about 16.92%[21] - Total current liabilities increased to ¥1,028,626,126.43 from ¥908,269,618.57, marking a rise of about 13.21%[21] - Total liabilities increased to ¥1,033,918,082.54 from ¥913,937,242.98, reflecting an increase of approximately 13.14%[21] - Total equity attributable to shareholders decreased to ¥2,945,781,791.14 from ¥2,962,954,448.62, a decline of about 0.58%[22] Other Financial Metrics - Cash and cash equivalents net increase decreased by CNY 72.0280 million, a decline of 209.91%, primarily due to increased cash flow from investing activities[14] - Cash and cash equivalents decreased to ¥175,781,800.85 from ¥213,477,158.97, a reduction of approximately 17.66%[20] - The total cash and cash equivalents at the end of the period were 175,718,820.80, down from 484,189,058.49 in the previous period, a decrease of approximately 63.7%[27] - The company received cash from other financing activities amounting to 966,000,000.00, an increase from 746,000,000.00 in the previous period, reflecting a growth of about 29.5%[27] Changes in Specific Accounts - The company’s financial assets increased by CNY 115,165,133.57, a growth of 94.78% compared to the previous year[8] - Prepayments increased significantly by 620.59%, totaling CNY 56,241,716.07[10] - The company’s contract liabilities rose by 144.77%, reaching CNY 14,525,971.24[9] - Other non-current assets increased by 30.52%, amounting to CNY 1,669,798,941.49[9] - Contract liabilities increased by CNY 8.5914 million, a growth of 144.77%, mainly due to an increase in advance payments received[12] - Employee compensation payable decreased by CNY 1.5648 million, a reduction of 42.01%, primarily due to the issuance of bonuses for the year 2024[12] - Other payables increased by CNY 9.4155 million, a surge of 14,155.67%, mainly due to an increase in dividends payable to shareholders[12] Impairment and Income Changes - Other income decreased by CNY 4.0475 million, a reduction of 38.77%, mainly due to a decrease in government subsidies received[13] - Investment income decreased by CNY 6.3308 million, a decline of 68.76%, primarily due to cash management not maturing and income not being recognized[13] - Asset impairment losses increased by CNY 0.5125 million, a rise of 826.61%, mainly due to provisions for inventory write-downs[13]

Financial Performance - The company's revenue for Q3 2025 reached ¥6,003,789,053.33, representing a year-on-year increase of 6.75%[4] - The net profit attributable to shareholders was a loss of ¥168,933,000.95, a decline of 393.61% compared to the same period last year[4] - Total operating revenue for the current period is ¥18,211,617,623.42, a decrease of 0.77% from ¥18,352,630,247.47 in the previous period[18] - Net profit for the current period is -¥137,391,974.48, compared to a net profit of ¥205,715,187.28 in the previous period, indicating a significant decline[19] - The total comprehensive income for the period was -149,609,479.15, compared to 211,278,144.29 in the previous period[20] - Basic and diluted earnings per share were both -0.05, down from 0.07 in the previous period[20] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥945,422,070.43, down 22.49% from the previous year[4] - The net cash flow from operating activities was 945,422,070.43, down from 1,219,760,479.13 in the previous period, indicating a decrease of approximately 22.5%[23] - The cash inflow from operating activities totaled 20,056,812,909.88, a slight decrease from 20,213,133,087.95 in the previous period[23] - The cash outflow for purchasing goods and services was 18,010,502,059.47, compared to 17,669,894,371.87 in the previous period, reflecting an increase of about 1.93%[23] - The net cash flow from investing activities was -751,044,464.92, worsening from -595,144,638.27 in the previous period[23] - The cash inflow from financing activities was 5,502,393,618.12, slightly up from 5,501,361,223.44 in the previous period[23] - The net cash flow from financing activities was -89,094,863.97, an improvement from -209,164,311.47 in the previous period[23] - The ending cash and cash equivalents balance was 1,796,045,455.93, compared to 1,575,262,600.77 in the previous period, showing an increase of approximately 14%[23] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥24,744,950,273.64, a decrease of 2.43% from the end of the previous year[4] - Current liabilities totaled ¥9,978,430,260.03, down from ¥10,326,185,709.50, a decrease of about 3.36%[17] - Non-current liabilities decreased to ¥3,100,511,091.60 from ¥3,157,703,298.67, a decline of approximately 1.80%[17] - The company's total equity decreased to ¥11,666,008,922.01 from ¥11,877,274,753.70, reflecting a reduction of about 1.77%[17] Shareholder Information - Total number of common shareholders at the end of the reporting period is 56,604[12] - The largest shareholder, Shandong Energy Group New Materials Co., Ltd., holds 53.18% of shares, totaling 1,511,964,163 shares[12] - The second largest shareholder, Changan International Trust Co., Ltd., holds 2.65% of shares, totaling 75,386,218 shares[12] - The company has a total of 206,749,278 pledged shares by the largest shareholder[12] - The company has a total of 22,794,413 shares held in a repurchase account, representing 0.80% of the total share capital[13] Investment and Financial Assets - The company reported a significant increase of 605.78% in trading financial assets, totaling ¥26,101,835.90[8] - The investment income for the year-to-date period improved by 31.77%, amounting to a loss of ¥16,891,800.00[8] - The company reported an investment loss of -¥16,891,800.00, an improvement from -¥24,757,521.19 in the previous period[19] Inventory and Expenses - The company's inventory increased by 32.08% to ¥1,564,942,977.52 compared to the end of 2024[8] - Total operating costs increased to ¥18,417,312,313.10, up 1.22% from ¥18,195,994,774.86 in the previous period[18] - Research and development expenses for the current period were ¥489,838,854.21, slightly down from ¥510,332,285.17 in the previous period[19] Government Subsidies and Tax - The company recorded a government subsidy of ¥1,230,795.22 for the current period[6] - The company reported a decrease in tax refunds received, totaling 21,025,513.23 compared to 145,805,524.24 in the previous period[22]

曼卡龙珠宝股份有限公司 2025 年第三季度报告 证券代码：300945 证券简称：曼卡龙 公告编号：2025-071 曼卡龙珠宝股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、完 整。 3.第三季度财务会计报告是否经过审计 □是 否 1 曼卡龙珠宝股份有限公司 2025 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | | 年初至报告期末 | 年初至报告期末比上 | | | --- | --- | --- | --- | --- | --- | --- | | | | 增减 | | 年同期增减 | | | | 营业收入（元） | 608,221,492.12 ...

Financial Performance - Revenue for Q3 2025 reached ¥591,804,525.96, an increase of 41.26% year-over-year, and total revenue for the year-to-date is ¥1,726,836,067.21, up 67.03% compared to the same period last year[4] - Net profit attributable to shareholders for Q3 2025 was ¥113,148,380.58, a significant increase of 317.56% year-over-year, with year-to-date net profit at ¥268,201,511.54, up 216.26%[4] - Basic earnings per share for Q3 2025 was ¥0.09, reflecting a growth of 280.00% year-over-year, while diluted earnings per share also stood at ¥0.09[4] - The company reported a significant reduction in intangible assets by 91.05% to 45,045.16 million, primarily due to the sale of the Espanyol Club[7] - The net profit for the current period is CNY 268,501,323.43, a significant recovery from a net loss of CNY 231,513,811.78 in the previous period[32] - The company reported a total comprehensive income of CNY 284,244,546.45, recovering from a loss of CNY 240,099,609.40 in the prior period[33] Cash Flow and Assets - Cash flow from operating activities for the year-to-date was ¥408,266,801.22, a substantial increase of 259.78% compared to the previous year[4] - Cash and cash equivalents increased by 251.48% to 68,994,572.62 compared to the previous year[43] - The company's current assets totaled RMB 1.12 billion, a substantial increase from RMB 475.20 million at the beginning of the period, representing a growth of approximately 135%[29] - The company's cash and cash equivalents increased to RMB 194.23 million from RMB 92.44 million, marking a growth of approximately 109%[28] - The cash and cash equivalents at the end of the period amounted to CNY 125,029,288.88, compared to CNY 121,281,631.19 at the end of the previous period[36] Liabilities and Equity - The company's total assets decreased by 8.71% from the end of the previous year, amounting to ¥3,460,323,143.65[5] - Shareholders' equity attributable to the parent company increased by 18.93% year-over-year, reaching ¥1,717,990,579.98[5] - The company's total liabilities decreased to RMB 1.75 billion from RMB 2.35 billion, showing a reduction of about 25.6%[30] - Total liabilities decreased significantly, with contract liabilities down by 64.99% and employee compensation payable down by 83.47% due to the sale of the Espanyol Club[11] Research and Development - Research and development expenses decreased by 50.07% year-over-year to ¥39,589,790.32, indicating a strategic shift in investment[8] - Research and development expenses decreased to CNY 39,589,790.32 from CNY 79,283,377.87, a reduction of about 50%[32] Business Segments and Operations - The toy business maintained stable growth in both revenue and net profit, driven by product structure upgrades and deep channel development[22] - New products launched in the toy segment included high-end remote-controlled cars and bicycles, enhancing the product matrix[22] - The game business saw significant revenue contributions from multiple game launches, achieving profitability for the first three quarters[23] - The game "Ragnarok: Dawn" topped the iOS free charts in Taiwan on its launch day, achieving high rankings in various regions[23] - The self-developed strategy game "Three Kingdoms: Strategy in the Nine Provinces" began full-platform public testing in October 2025, ranking first on several app store charts[24] - The company continues to explore deep cooperation opportunities with international IPs to support long-term growth in the toy business[22] Investment and Gains - Non-recurring gains and losses for Q3 2025 totaled ¥50,592,110.32, with significant contributions from asset disposal gains and government subsidies[6] - Investment income increased by 11,806.25% to 5,300.81 million, resulting from the recognition of investment gains from the sale of the Espanyol Club[30] - The company achieved an investment income of CNY 52,559,136.89, a significant improvement from a loss of CNY 448,983.72 in the previous period[32]

Financial Performance - The company's operating revenue for the third quarter reached ¥84,781,750.41, representing a year-on-year increase of 164.39%[3] - The net profit attributable to shareholders was ¥15,943,078.67, an increase of 176.31% compared to the same period last year[3] - The net profit after deducting non-recurring gains and losses was ¥15,149,596.72, up 168.35% year-on-year[3] - The net profit attributable to the parent company increased by 93.33% year-on-year, driven by the sales profit from the new product[8] - The company's operating profit for the current period was -7,394,530.37, an improvement from -51,330,965.44 in the previous period, indicating a significant reduction in losses[25] - The total profit for the current period was -7,538,875.32, compared to -51,363,813.55 in the previous period, reflecting a substantial decrease in overall losses[25] - The net profit attributable to the parent company's shareholders was -2,523,479.07, a notable improvement from -37,837,689.22 in the previous period[25] Cash Flow - The net cash flow from operating activities increased by 262.79% year-to-date, totaling ¥32,081,773.07[3] - Cash inflow from operating activities totaled 191,244,462.63, compared to 151,475,766.86 in the previous period, showing a year-over-year increase[27] - Cash outflow from operating activities was 159,162,689.56, down from 171,182,964.84 in the previous period, indicating improved cash management[27] - The net cash flow from investing activities was -51,390,022.73, worsening from -16,061,574.38 in the previous period[27] - The net cash flow from financing activities was 2,614,710.40, a significant decrease from 69,322,933.39 in the previous period[27] - The ending cash and cash equivalents balance was 28,699,487.14, down from 37,070,882.11 in the previous period, reflecting a decline in liquidity[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥797,770,471.93, a 1.77% increase from the end of the previous year[3] - The company's total assets increased to ¥797,770,471.93 from ¥783,866,026.52, reflecting a growth of 1.15%[22] - Total liabilities rose to ¥393,424,894.74 from ¥372,260,377.26, marking an increase of 5.1%[22] - The total equity attributable to shareholders decreased to ¥390,893,020.73 from ¥393,409,970.88, a decline of 0.4%[22] - Cash and cash equivalents decreased to ¥28,699,487.14 from ¥45,105,842.30, a drop of 36.2%[20] - Inventory increased to ¥85,659,863.26 from ¥80,535,394.02, an increase of 6.6%[20] - The company’s investment properties decreased to ¥15,493,180.48 from ¥17,597,890.39, a decline of 11.97%[20] Operating Costs and Expenses - The company reported a 33.04% increase in total operating income year-on-year, primarily due to the sales of the newly listed product, paclitaxel injection (albumin-bound)[7] - The cost of goods sold increased by 43.79% year-on-year, attributed to the higher production costs of the new product[7] - Research and development expenses decreased by 39.76% year-on-year, reflecting reduced investment in research activities[8] - Research and development expenses decreased to ¥6,040,736.81 from ¥10,028,401.53, a reduction of 39.6%[24] - Total operating costs decreased slightly to ¥180,108,046.32 from ¥180,496,024.50, with operating costs specifically rising to ¥73,115,398.25 from ¥50,847,128.40, indicating a significant increase of 43.8%[24] - The company experienced a 391.31% increase in non-operating expenses year-on-year, mainly due to increased losses from fixed asset disposals[8] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 44,166[12] - The largest shareholder, Hainan Shuangcheng Investment Co., Ltd., holds 32.92% of the shares, totaling 136,516,546 shares[12] Investment Activities - Investment cash inflows decreased by 55.19% compared to the same period last year, primarily due to a reduction in the recovery of financial investments[10] - Cash paid for investments decreased by 46.30% year-on-year, mainly due to a reduction in financial investments during the reporting period[10] - Net cash flow from investment activities decreased by 219.96% compared to the same period last year, primarily due to a decrease in net cash flow from financial investments[10] - Cash received from investment increased by 262.67% year-on-year, mainly due to an increase in stock subscription payments during the reporting period[10] Audit Status - The company has not undergone an audit for the third quarter financial report[29]

Financial Performance - The company's revenue for Q3 2025 was ¥643,647,540.63, a decrease of 1.96% compared to the same period last year[5]. - The net profit attributable to shareholders was ¥10,682,468.20, down 29.90% year-over-year[5]. - The net profit after deducting non-recurring gains and losses was ¥6,789,290.78, a decline of 47.83% compared to the previous year[5]. - The operating cash flow for the year-to-date period was ¥23,256,149.48, reflecting a significant decrease of 70.82%[5]. - Total operating revenue for the current period is ¥1,882,462,548.88, a decrease of 2.45% compared to ¥1,929,843,801.69 in the previous period[58]. - Net profit for the current period is ¥61,253,540.39, a decline of 5.56% from ¥64,653,431.11 in the previous period[59]. - Operating profit decreased to ¥84,829,692.12, down 13.83% from ¥98,472,510.51 in the previous period[59]. - Basic and diluted earnings per share decreased to ¥0.0657 from ¥0.0686 in the previous period[59]. - The company’s total profit for the current period is ¥83,895,528.42, down from ¥101,956,515.35 in the previous period[59]. Assets and Liabilities - The total assets at the end of the reporting period were ¥3,816,126,330.76, an increase of 2.80% from the end of the previous year[5]. - Total current assets increased to ¥1,741,012,968.26 from ¥1,608,572,076.75, reflecting a growth of approximately 8.2%[54]. - Current liabilities decreased slightly to ¥1,370,362,290.32 from ¥1,379,633,066.20, a reduction of approximately 0.2%[55]. - The company reported a total equity of ¥1,866,496,118.04, an increase from ¥1,806,997,755.53, representing a growth of about 3.3%[57]. - The company’s cash and cash equivalents rose to ¥187,951,511.04 from ¥151,393,279.42, marking an increase of approximately 24.2%[54]. - The company’s inventory decreased to ¥202,070,061.15 from ¥214,338,468.42, a decline of about 5.7%[54]. - The company’s retained earnings improved to -¥746,876,506.23 from -¥796,367,861.42, reflecting a positive change of approximately 6.2%[57]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 68,039[11]. - The largest shareholder, Gome Holdings Group Co., Ltd., holds 24.71% of shares, totaling 186,113,207 shares[11]. - Gome Electrical Appliances Co., Ltd. holds 6.64% of shares, totaling 50,000,000 shares[11]. - The number of shares pledged by Gome Holdings Group is 111,601,400, with 182,466,343 shares frozen[12]. - Gome Holdings has pledged 111,601,400 shares, accounting for 59.96% of its holdings, which represents 14.82% of the company's total share capital[16]. - Gome Electrical Appliances has 50,000,000 shares pledged, which is 100% of its holdings, representing 6.64% of the company's total share capital[16]. - The total number of shares under judicial freeze for both Gome Holdings and Gome Electrical Appliances is 172,903,529 shares, representing 73.23% of their total holdings and 22.96% of the company's total share capital[17]. - Gome Holdings has 59,562,814 shares under cumulative pending freeze, which is 32.00% of its holdings and 7.91% of the company's total share capital[18]. - The total number of shares under pending freeze for Gome Electrical Appliances is 2,709,313,426 shares, which is 5,418.63% of its holdings and 359.74% of the company's total share capital[18]. Corporate Governance - The company completed the election of the ninth board of directors and the supervisory board on January 23, 2025[13]. - The new president appointed is Hou Zhajun, along with several vice presidents[14]. - The independent director Dong Lei will no longer serve after the board transition[14]. - The company has established various specialized committees within the new board, including an audit committee and a strategic committee[14]. - The company has no changes in the top 10 shareholders due to securities lending activities[13]. Product Development and Regulatory Approvals - Beijing Huasu received the acceptance notice for the consistency evaluation application of Tramadol Hydrochloride Tablets (50mg), marking the entry into the review stage[30]. - Dodo Pharmaceutical's Eleutherococcus Injection was selected in the national traditional Chinese medicine procurement alliance, with a winning price of 13.18 RMB per 20ml vial[31]. - The procurement cycle for the selected Eleutherococcus Injection lasts until December 31, 2027, which may enhance market coverage and brand influence[32]. - Beijing Huasu's production license was updated to include the production of raw material drug Benzyl Benzoate, enhancing production capacity and compliance with GMP standards[33][34]. - Beijing Huasu's Hydroxycodone Controlled-Release Tablets (40mg) received acceptance for market registration, entering the review phase[37]. - Zhongshi New Materials and Shandong Huasu Health Care Products both received high-tech enterprise certificates, allowing for a reduced corporate income tax rate of 15% for three years[36]. - Duoduo Pharmaceutical's application for the marketing authorization of Bromhexine Hydrochloride Injection (2ml:4mg) has been accepted by the National Medical Products Administration, marking the start of the review phase[38]. - Beijing Huasu's Naloxone Injection (1ml:1mg) has been selected in the 10th batch of national centralized drug procurement, with a winning price of 0.99 RMB per unit, which will enhance the company's market presence and sales channels[39][40]. - Shandong Huasu's application for the marketing authorization of Bisoprolol Amlodipine Tablets (5mg each) has been accepted, indicating progress in the product's market competitiveness[41]. - Duoduo Pharmaceutical's Tramadol Hydrochloride Injection (2ml:100mg) has passed the consistency evaluation for generic drugs, which will positively impact the company's operational performance[46]. - The acceptance of multiple drug applications by the National Medical Products Administration indicates a strategic focus on expanding the product portfolio and enhancing market competitiveness[38][41][44].

Financial Performance - The company's operating revenue for Q3 2025 reached ¥611,378,481.35, representing a year-on-year increase of 14.35% and a cumulative increase of 23.69% for the year-to-date[5] - Net profit attributable to shareholders for Q3 2025 was ¥169,458,642.12, up 14.99% year-on-year, with a year-to-date increase of 29.39% totaling ¥496,134,859.58[5] - The basic earnings per share for Q3 2025 was ¥0.62, reflecting a 14.81% increase compared to the same period last year[5] - Total operating revenue for the current period reached ¥1,781,395,805.57, an increase of 23.7% compared to ¥1,440,203,195.39 in the previous period[22] - The net profit for the current period is CNY 496,134,859.58, an increase of 29.4% compared to CNY 383,454,765.27 in the previous period[23] - The total comprehensive income for the current period is CNY 497,340,817.13, up from CNY 383,803,439.34, reflecting a growth of 29.6%[24] - Basic and diluted earnings per share both increased to CNY 1.82 from CNY 1.41, representing a rise of 29.1%[24] - The company reported a significant increase in sales revenue from CNY 693,546,624.23 to CNY 1,076,242,644.80, reflecting a growth of 55.2%[24] Assets and Liabilities - Total assets as of September 30, 2025, amounted to ¥6,643,998,971.68, showing a slight increase of 0.35% from the end of the previous year[5] - The company's equity attributable to shareholders increased by 12.05% to ¥3,881,931,442.41 compared to the end of the previous year[5] - Total assets increased slightly to ¥6,643,998,971.68 from ¥6,620,776,016.29, reflecting a growth of 0.35%[21] - Total liabilities decreased to ¥2,762,067,529.27 from ¥3,156,366,470.25, a reduction of 12.5%[21] Cash Flow - Cash flow from operating activities for the year-to-date reached ¥11,329,106.88, a significant increase of 113.40% compared to the same period last year[5] - The net cash flow from operating activities is CNY 11,329,106.88, a significant recovery from a negative CNY 84,554,539.54 in the previous period[24] - Cash inflow from operating activities reached CNY 1,134,249,540.47, compared to CNY 866,664,028.69 in the previous period, marking a growth of 30.8%[24] - The cash flow from investing activities resulted in a net outflow of CNY 43,874,892.80, slightly improved from a net outflow of CNY 47,894,539.53 in the previous period[25] - Cash and cash equivalents at the end of the period totaled CNY 347,031,040.41, compared to CNY 206,551,571.55 at the end of the previous period, indicating an increase of 68.1%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 19,738[13] - Major shareholder Li Zhigang holds 39.87% of shares, totaling 109,073,070 shares[13] - The second-largest shareholder, Duan Xiaoting, holds 7.65% of shares, totaling 20,919,394 shares[13] - Li Zhigang directly controls 39.87% of the company's shares and indirectly controls an additional 1.67% through Wuhan Suneng, totaling 41.54%[14] - The company has a total of 105,959,631 restricted shares held by executives, which remain locked under regulations[17] - There are no changes in the number of shares lent or returned under margin trading by the top 10 shareholders[14] - The company has no preferred shareholders or changes in restricted shares during the reporting period[15] - The total number of shares held by the top 10 unrestricted shareholders is also notable, with significant holdings by various funds and individuals[14] - The company maintains a strong governance structure with major shareholders actively involved in management[14] Operating Costs and Expenses - Total operating costs amounted to ¥1,214,834,772.46, up 17.9% from ¥1,029,557,484.51 in the prior period[22] - Research and development expenses were ¥178,453,052.84, a decrease of 15.3% from ¥210,655,964.52 year-over-year[22] - The company incurred a total of CNY 572,097.55 in non-operating expenses, a substantial increase from CNY 33,922.23 in the previous period[23] - The company received CNY 29,459,703.49 in tax refunds, down from CNY 80,836,113.58 in the previous period, indicating a decrease of 63.6%[24] Investment and Financial Assets - The company reported a 211.23% increase in trading financial assets, totaling ¥280,930,419.51, due to investments in cash management products during the reporting period[11] - The company experienced a 58.97% decrease in fair value changes in profit, amounting to ¥10,666,668.51, attributed to reduced fair value changes in equity assets held[11] - Interest income decreased by 30.78% to ¥40,976,742.23, primarily due to a reduction in large-denomination certificates of deposit[11] - The company reported a net cash outflow from financing activities of ¥91,491,707.10, a decrease of 41.35% compared to the previous period, mainly due to share buybacks in the prior year[11] - Long-term investments increased significantly to ¥23,562,971.09 from ¥6,031,351.85, marking a growth of 290.5%[20]

福建三木集团股份有限公司 2025 年第三季度报告 福建三木集团股份有限公司 2025 年第三季度报告 证券代码：000632 证券简称：三木集团 公告编号：2025-96 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | | | | 期增减 | | 年同期增减 | | 营业收入（元） | 847,395,268.88 | -67.77% | 4,608,979,663.29 | -51.14% | | 归 ...

Revenue and Profit - Q3 2025 revenue was CNY 1,719,568,456.47, a decrease of 7.00% year-over-year, while year-to-date revenue decreased by 10.20% to CNY 4,937,772,752.89[5] - Net profit attributable to shareholders for Q3 2025 was CNY 407,721,562.17, down 4.37% year-over-year, with a year-to-date net profit of CNY 1,062,397,662.45, a decline of 6.57%[5] - Basic and diluted earnings per share for Q3 2025 were both CNY 0.38, reflecting a decrease of 5.00% compared to the same period last year[5] - Total operating revenue decreased to ¥4,937,772,752.89 from ¥5,498,404,185.59, representing a decline of approximately 10.2% year-over-year[20] - Net profit for the period was ¥1,062,397,662.45, down from ¥1,137,161,185.76, reflecting a decline of approximately 6.6% year-over-year[21] - The company reported a total comprehensive income of ¥1,053,996,074.13, down from ¥1,141,919,894.60, a decrease of approximately 7.7% year-over-year[22] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 41.25% to CNY 1,520,175,783.00[5] - Cash flow from operating activities generated ¥1,520,175,783.00, an increase from ¥1,076,260,253.42, indicating a growth of approximately 41.2% year-over-year[22] - The net cash flow from investment activities for the year-to-date period was CNY -2,674,229,476.46, an increase of 49.89% in outflows compared to the previous year[11] - Cash inflow from investment activities surged to ¥6,944,768,571.69, up from ¥3,558,697,048.60, marking an increase of about 95.5% year-over-year[22] - Net cash flow from investment activities was negative at approximately -$2.67 billion, compared to -$1.78 billion previously[23] - The net increase in cash and cash equivalents was approximately -$1.36 billion, compared to -$756.31 million previously[23] - The ending balance of cash and cash equivalents was approximately $1.68 billion, down from $2.75 billion[23] Assets and Liabilities - Total assets at the end of the reporting period were CNY 14,956,822,297.46, an increase of 5.08% from the previous year-end[5] - Total non-current assets increased from CNY 6,099,763,341.70 to CNY 7,241,329,322.91, reflecting an increase of about 18.7%[17] - The total assets of the company rose from CNY 14,233,330,315.32 to CNY 14,956,822,297.46, marking an increase of approximately 5.1%[17] - Total current liabilities decreased from CNY 3,959,204,095.80 to CNY 3,604,510,335.97, a reduction of about 8.9%[17] - Total liabilities decreased to ¥4,235,504,818.86 from ¥4,571,348,808.76, a reduction of approximately 7.3%[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11, with the largest shareholder, Guangdong Meiying Industrial Investment Co., holding 64.36% of shares[13] - The largest shareholder, Guangdong Meiying Industrial Investment Co., also controls several investment partnerships, indicating a consolidated ownership structure[13] - The company has a total of 10 major shareholders, with the top three holding a combined 91.21% of shares[13] Financial Performance Metrics - Financial expenses decreased by 72.49% to CNY -5,997,439.89, mainly due to reduced interest income[10] - Other income decreased by 59.71% to CNY 19,908,355.75, primarily due to a reduction in government subsidies[10] - Total operating costs reduced to ¥3,717,528,878.96 from ¥4,211,084,742.44, a decrease of about 11.7% year-over-year[20] - Deferred income increased to ¥34,259,718.66 from ¥39,672,950.51, indicating a decrease of about 13.8% year-over-year[18] Future Plans and Standards - The company plans to issue 119,492,000 shares in its initial public offering, which is set to be listed on October 22, 2025[14] - The company will implement new accounting standards starting in 2025[25] Audit Status - The third quarter financial report was not audited[24]